Business Description
Kodiak Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US50015M1099
Compare
Compare
Traded in other countries / regions
K27.GermanyKOD.MexicoKOD.USA IPO Date
2018-10-04Description
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.86 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | -0.3 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -71.4 | |||||
| 3-Year EPS without NRI Growth Rate | -72.3 | |||||
| 3-Year FCF Growth Rate | -66.8 | |||||
| 3-Year Book Growth Rate | 2.3 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.21 | |||||
| 9-Day RSI | 76.38 | |||||
| 14-Day RSI | 71.74 | |||||
| 6-1 Month Momentum % | -42.36 | |||||
| 12-1 Month Momentum % | -45.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.25 | |||||
| Quick Ratio | 6.25 | |||||
| Cash Ratio | 6.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -63.39 | |||||
| ROA % | -42.16 | |||||
| ROIC % | -168.04 | |||||
| ROC (Joel Greenblatt) % | -234.61 | |||||
| ROCE % | -46.38 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.05 | |||||
| Price-to-Tangible-Book | 1.05 | |||||
| EV-to-EBIT | -0.25 | |||||
| EV-to-Forward-EBIT | -0.28 | |||||
| EV-to-EBITDA | -0.26 | |||||
| EV-to-Forward-EBITDA | -0.3 | |||||
| EV-to-FCF | -0.3 | |||||
| Price-to-Net-Current-Asset-Value | 2.24 | |||||
| Price-to-Net-Cash | 2.37 | |||||
| Earnings Yield (Greenblatt) % | -400 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KOD
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Kodiak Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -5.91 | ||
| Beta | 1.88 | ||
| Volatility % | 67.78 | ||
| 14-Day RSI | 71.74 | ||
| 14-Day ATR ($) | 0.609188 | ||
| 20-Day SMA ($) | 5.7315 | ||
| 12-1 Month Momentum % | -45.22 | ||
| 52-Week Range ($) | 4.25 - 12.8 | ||
| Shares Outstanding (Mil) | 52.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kodiak Sciences Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kodiak Sciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kodiak Sciences Inc Frequently Asked Questions
What is Kodiak Sciences Inc(KOD)'s stock price today?
The current price of KOD is $7.84. The 52 week high of KOD is $12.80 and 52 week low is $4.25.
When is next earnings date of Kodiak Sciences Inc(KOD)?
The next earnings date of Kodiak Sciences Inc(KOD) is 2023-08-09 Est..
Does Kodiak Sciences Inc(KOD) pay dividends? If so, how much?
Kodiak Sciences Inc(KOD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers